Keystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device Post author:Sam Post published:August 1, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Biogen Halts Plans to Develop Tysabri for Stroke After Phase IIb Trial Flop February 6, 2018 Cantrell Drug Company Files for Chapter 11 Bankruptcy November 7, 2017 Former Top Biotech Analyst Charged With Insider Trading September 26, 2017